Ruyu Han, Lu Chen, Ping Chen, Tianqiang Song. "Tislelizumab as monotherapy or in sequential combination with lenvatinib for neoadjuvant treatment of resectable hepatocellular carcinoma: A prospective, phase II clinical study.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e16292